skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Is this a suitable stock for 7 to 8 years duration for an RESP? This is a first time question. Love to see you when you are on BNN TV.

Thanks. Vic
Read Answer Asked by Victor on August 17, 2018
Q: What are your thoughts on Absolute Software. I never sold it out of my portfolio and things look better after they reported a few days ago. Do you think someone would be interested in buying them or from your experience is there a chance they may go private. I am reluctant to sell but I worry in a downturn about these small names like Absolute and Sylogist—both taken out of the portfolio but appear to have good momentum.
Read Answer Asked by Helen on August 16, 2018
Q: Hi All at 5i! My niece has accumulated $10,000 and has a 15 to 20 year horizon. Could you please suggest two income and growth and two growth stocks that would make up a good core holding for that time frame ? Cheers, Tamara
Read Answer Asked by Tamara on August 16, 2018
Q: I would like to reduce my utility / infrastructure holdings by one or two names. These are all partial positions except for FTS, which is full. Could you rank 1 - 7 in terms of keep:sell or just suggest one or two sell candidates? Thank-you.
Read Answer Asked by David on August 16, 2018
Q: This question is relating to the tax consequences of accepting the offer by BIP. The ECI shares are held in a non-registered account.
By tendering ECI shares, an investor will receive in exchange cash and units in BIP.UN. The exchange for cash will result in a capital gain which is taxable. Will the exchange of ECI shares for BIP.UN be a deemed disposition of the ECI shares or is it a tax free roll over?
Read Answer Asked by Ron on August 16, 2018
Q: Good Morning to you all ,i appreciate all the great advice .I own jd.com here i am down on it.What are your thoughts on it and the continual slide,Is it worth keeping or should i cut my loss. i thought with google investing into it there would be better results ..Thanks for your opinion Norm
Read Answer Asked by Norman on August 16, 2018
Q: Today Rose Ambrose ,who is involved in the NAFTA talks, indicated that unless Canada compromises Trump will impose the 25% auto tariffs on September 1, 2018.

So how can Canada negotiate/compromise if our negotiators are not invited to participate in the negotiations between the Mexicans and the Americans.

Since very little time is left between now and September 1, 2018 and since Canada is sidelined, is it fair to assume that Trump’s 25% auto tariffs will be implemented?

What is your opinion?
Read Answer Asked by Terry on August 16, 2018
Q: Hi there, I owned ala.r which were converted into ala. On my statements, the firm took back all the dividend income I received from March to July of this year (even though it was supposed to be interest income, not dividend income). I got a return of capital and interest equaling the dividend amount clawed back. The vast majority was ROC, with minuscule interest. Ala.r was supposed to pay an equivalent amount of interest to holders of ala.r as the dividend was. So since March 18 I did not receive that, just a little interest. The way I calculate it, Alta gas got the use of my investment for five months basically free. Do you agree. Tx. John
Read Answer Asked by John on August 16, 2018
Q: I have complied a list of what I believe are all high quality microcap stocks with current market valuations that are still very attractive and have good upside potential over the next 12 months. How does 5i ranks these stocks and am I missing some obvious microcap stocks with similar traits?
Read Answer Asked by Charles on August 16, 2018
Q: Hi guys,
Given the strong suggestions Trump will carry through with his threat for a 25% tariff on Canadian autos next month, and the rock solid guarantee this would lead to a huge drop in the Canadian markets, would you delay new investments in Canadian companies for a bit?
Read Answer Asked by John on August 16, 2018
Q: Are you aware of any pharmaceutical companies involved in clinical trials of products used to treat actinic keratosis, a very common skin condition in seniors caused by sun exposure (sun damaged skin)? The main current treatment is with Efudex, supplied in Canada by Valeant. Treatment with Efudex is effective, but a bit brutal, akin to burning the outer layer of skin, causing short term discomfort and disfigurement (personal experience). A Dermatologist I saw recently stated that there are a number of current clinical trials taking place with alternative treatments of a more benign nature. He felt that this would be revolutionary in treatment and suggested that these companies would be extremely successful given the frequency of the problem and the escalating risks of sun exposure. He did not provide any specific company information. Any information that you or your members could provide would be helpful in researching a speculative investment.
thanks, Len
Read Answer Asked by Leonard on August 16, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!